Sign in to view content

Anti-VEGF/Anti-Angiopoietin-2 Bispecific Antibody RG7716 in Diabetic Macular Edema: 36-Week Results From the Phase 2 BOULEVARD Clinical Trial

Rishi P. Singh, MD

Video
Published 2018

Related

Episode 14: Plasma VEGF Levels After Anti-VEGF Injections (DRCR protocol T) with Dr. Charles Wykoff
Keyvan Koushan, MD, FRCSC
Member Podcasts
2018
Direct-to-Consumer Marketing by U.S. Cell Therapy Clinics for Retinal Conditions
Ajay E Kuriyan, MD, MS
Annual Meeting Talks
2018
OCT Angiography (OCTA) Monitors The Influence of Different VEGF-I Drugs on a Specific CNVM
Anne M. Hanneken, MD
Annual Meeting Talks
2018

Category: Diabetic Retinopathy

See more